Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (13290)	1/14/1998 7:17:00 AM
From: Henry Niman	Respond to of 32384

V1, Thanks for the update. I have updated Ligand Links home.att.net to include links to reports by attendees (medsunman, Bernie, V1). I have updated the BancAmerica Robertson Stephens sector of analyst reports home.att.net to include the press release on initiation of coverage. At the time (Nov, 1996) Hurwitz predicted that annual retinoid sales would reach $500 million. These numbers are consistant with DR's talk yesterday, where he predicted annual sales of $500 million for cancer indications (as long as expanded results were consistant with interim results). I have also included links to some discussion of the 10 year projections, including an EPS of $14.55 in 2006 (which I still think is conservative).